Shelby Clinical Research — Shelby, North Carolina

Shelby Clinical Research is a clinical research site located in Shelby, North Carolina, United States 28150.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Shelby Clinical Research has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Chronic Uncontrolled Gout, Gout, Uncontrolled Gout.

Sponsors: Amgen, Eli Lilly and Company, Crystalys Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Shelby

Browse all research sites in North Carolina · View every site in Shelby

• Atrium Health Cleveland/LCI-Cleveland
• Carolina Research Center
• GSK Investigational Site
• Novartis Investigative Site
• CORE
• Cleveland Hematology and Oncology Associates PC
• Research Site
• Vita Eye Clinic
• Novo Nordisk Investigational Site
• Carolinas HealthCare System Cleveland
• CYS-005 Investigational Site

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Shelby Clinical Research?

Shelby Clinical Research has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Shelby Clinical Research conducted?

Shelby Clinical Research has 9 clinical trials on record, with 5 currently active. Their work covers Chronic Uncontrolled Gout, Gout, Uncontrolled Gout.

Is Shelby Clinical Research accredited by Crixeo Clinical Trials?

Shelby Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Shelby Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.